Trexquant Investment LP Takes $9.30 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trexquant Investment LP purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 17,819 shares of the medical equipment provider's stock, valued at approximately $9,301,000.

Several other institutional investors have also recently made changes to their positions in the company. Atala Financial Inc bought a new position in Intuitive Surgical in the 4th quarter worth about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. Summit Securities Group LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $31,000. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares of the company's stock, valued at $271,397.94. The trade was a 63.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 492 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $282,299.76. Following the sale, the senior vice president now directly owns 4,056 shares in the company, valued at $2,327,251.68. This trade represents a 10.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Truist Financial dropped their price target on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a research note on Monday, March 17th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Robert W. Baird reduced their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 18th. Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $611.86.

Intuitive Surgical Stock Down 8.7 %

Shares of ISRG stock traded down $43.03 during mid-day trading on Friday, reaching $451.58. 4,106,917 shares of the company's stock traded hands, compared to its average volume of 1,542,647. The company's 50-day moving average price is $545.18 and its 200-day moving average price is $532.30. The company has a market cap of $160.84 billion, a P/E ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.